LAG-3, an emerging immune checkpoint molecule, is often co-expressed with PD-1 in infiltrating lymphocytes of gastric cancer, and its high expression is frequently accompanied by upregulation of PD-L1 and CTLA-4, as well as higher TMB [51]. Here, LAG3 is linked to gastric cancer.